摘要
目的构建并鉴定人蛋白酪氨酸磷酸酶基因(SHP-1)重组腺病毒Ad-SHP1。方法将人SHP-1cDNA克隆于穿梭质粒pAdTrack-CMV,Pme线性化后,与腺病毒骨架质粒pAdEasy-1共转化BJ5183细菌,获得带有SHP-1基因的重组腺病毒质粒pAd-SHP1,经Pac线性化后通过Lipofectamine2000转染HEK293包装细胞,观察细胞内绿色荧光蛋白表达情况。收获重组腺病毒,经PCR和WesternBlotting鉴定后,扩增并纯化重组腺病毒,测定病毒滴度。结果经测序、酶切电泳和感染后蛋白表达检测均表明成功构建重组腺病毒Ad-SHP1;病毒滴度为1.58×1010pfu/mL。结论成功构建带有人SHP-1cDNA的重组腺病毒,为进一步研究结外鼻型NK/T细胞淋巴瘤发生机制及肿瘤的基因治疗奠定了基础。
Objective To construct and identify recombinant adenovirus Ad-SHP1 carrying human SH2 domain-containing protein tyrosine phosphatase (SHP-1). Methods Human SHP-1 cDNA from healthy volunteers' peripheral blood lymphocyte was cloned into the shuttle plasmid pAdTrack-CMV by standard procedure. The plasmid pAdTrackCMV-SHP1 was selected and then linearized by Pine I , followed by homologous recombination with bone plasmid pAdEasy-1 in BJ5183. Recombinant adenovirus Ad-SHP1 were obtained after packaged in HEK293 cells and the green fluorescence in HEK293 cells was observed. Recombinant adenovirus was confirmed with PCR and the expressed SHP-1 protein was verified with Western Blotting. Ad- SPlP1 was multiplied and purified. The titer of virus was measured with fluorescent counter. Results The results of sequencing, restriction endounclease digestion and Western Blotting indicated that Ad-SHP1 was successfully constructed. The titer of Ad-SHP1 reached 1.58×10^10 pfu/mL. Conclusion Recombinant adenovirus Ad-SHP1 had been successfully constructed. It could express SHP-1 protein stably and effectively and this will be very helpful for the further study of the generation of extranodal NK/T cell lymphoma and the corresponding therapy.
出处
《四川大学学报(医学版)》
CAS
CSCD
北大核心
2007年第4期561-564,共4页
Journal of Sichuan University(Medical Sciences)
基金
国家自然科学基金(批准号30470747)资助